Publicaciones en colaboración con investigadores/as de Instituto de Investigación Sanitaria Biobizkaia (13)

2023

  1. Analysis of the impact of handling and culture on the expansion and functionality of NK cells

    Frontiers in Immunology, Vol. 14

  2. Towards tailored surface topography on electrospun wound dressings for exudate absorption

    Surface Innovations, Vol. 12, Núm. 3-4, pp. 252-264

2022

  1. Identifying SARS-CoV-2 ‘memory’ NK cells from COVID-19 convalescent donors for adoptive cell therapy

    Immunology, Vol. 165, Núm. 2, pp. 234-249

2021

  1. Evaluation of the Spanish population coverage of a prospective HLA haplobank of induced pluripotent stem cells

    Stem Cell Research and Therapy, Vol. 12, Núm. 1

  2. The race of CAR therapies: CAR-NK cells for fighting B-cell hematological cancers

    Cancers, Vol. 13, Núm. 21

  3. Two new RHD alleles with deletions spanning multiple exons

    Transfusion, Vol. 61, Núm. 3, pp. 682-686

2020

  1. A multi-centre study on the performance of the molecular genotyping platform ID RHD XT for resolving serological weak RhD phenotype in routine clinical practice

    Vox Sanguinis, Vol. 115, Núm. 3, pp. 241-248

  2. Generation, establishment and characterization of a pluripotent stem cell line (CVTTHi001-A) from primary fibroblasts isolated from a patient with activated PI3 kinase delta syndrome (APDS2)

    Stem Cell Research, Vol. 49

2019

  1. Adult peripheral blood and umbilical cord blood NK cells are good sources for effective CAR therapy against CD19 positive leukemic cells

    Scientific Reports, Vol. 9, Núm. 1

2017

  1. OP9 feeder cells are superior to M2-10B4 cells for the generation of mature and functional natural killer cells from umbilical cord hematopoietic progenitors

    Frontiers in Immunology, Vol. 8, Núm. JUN

2016

  1. The expression and function of human CD300 receptors on blood circulating mononuclear cells are distinct in neonates and adults

    Scientific Reports, Vol. 6

2014

  1. Involvement of platelet-tumor cell interaction in immune evasion. Potential role of podocalyxin-like protein 1

    Frontiers in Oncology

  2. Natural killer cells for cancer immunotherapy: Pluripotent stem cells-derived NK cells as an immunotherapeutic perspective

    Frontiers in Immunology